Regulatory Approvals
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Track global regulatory approvals for new drugs and biologics. Stay ahead in pharma BD with critical FDA, EMA, and PMDA insights.
Showing 1–6 of 6 articles
Quick answer
NovaPharmaNews Regulatory Approvals hub for FDA covers 6 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
FDA Approval for Pfizer's Breast Cancer Drug: Vepdegestrant
Axsome FDA Approval for Alzheimer's Agitation Drug
FDA Approves First Non-Antipsychotic for Dementia Agitation
Plozasiran TGA Approval: REDEMPLO® Now Available in Australia for FCS
Teva Reports Strong Q1 2026 Results as PONLIMSI Biosimilar Receives FDA Approval and Olanzapine LAI Advances
CGBIO Receives FDA 510(k) Clearance for EASYMADE TI Patient-Specific Titanium Implant
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.